Making early cancer diagnosis possible
Chip Diagnostics is an emerging leader in exosome-based diagnostics, enabling minimally invasive disease detection and monitoring. We unlock the potential of liquid biopsy by fingerprinting diseases with organ-specific signatures, providing actionable clinical data.
We envision Chip Diagnostics at the forefront of advancements in early cancer detection, therapy selection, and patient monitoring.
Our technology is designed to precisely find and interpret disease-specific exosomes in the blood, with the goal of being able to accurately assess disease.